The work described here covers an examination of new bioproducts based on sub-Saharan bryophytes. The work includes in vitro testing of extracts from moss and liverworts against plant pathogenic microbes causing food decay and field crop losses. Additionally, we have shown specific antimicrobial activities of Marchantia debilis and moss against Erwinia spp and Pseudomonas spp. The extracts were also tested against aflatoxin-producing fungi isolated from food crops such as maize and peanuts. The efficacy of the extracts on clinical dermatological fungal isolates like Dermatophilus congolensis has not been reported. This led to the production of an antifungal solution of bryophyte extracts, which was tested in vivo on animals with skin diseases caused by Dermatophilosis. Around 99.5% of the animals were treated. The antifungal solution for treatments has been labeled Bryosol, while the disinfectants solution is labeled Bryo-disinfectants and the crop-fungicide is labeled Bryo-fungicides. A mini field pilot trial with Bryo-fungicide showed that crops infected with pathogenic fungi were treated. The results provide the first attempt to demonstrate the use of bioproducts for organic treatment of agricultural crops and diseases in animals based on sub-Saharan bryophytes.
Part of the book: Biotechnology and Bioengineering